Search
Universe Pharmaceuticals Inc
UPCAdd to Watchlist
6.320USD
+0.760+13.67%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
3.56MMarket Cap
0.00P/E TTM
More Details of Universe Pharmaceuticals Inc Company
Universe Pharmaceuticals Inc is a China-based holding company mainly engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives (TCMD) products targeting the elderly. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The Company mainly conducts its businesses within the Chinese market.
Universe Pharmaceuticals Inc Info
Ticker SymbolUPC
Company nameUniverse Pharmaceuticals Inc
IPO dateMar 23, 2021
CEOLai (Gang)
Number of employees225
Security typeOrdinary Share
Fiscal year-endMar 23
Address265 Jingjiu Avenue
CityJI'AN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code343100
Phone867968403309
Websitehttp://www.universe-pharmacy.com/
Ticker SymbolUPC
IPO dateMar 23, 2021
CEOLai (Gang)
Company Executives of Universe Pharmaceuticals Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
71.89K
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
Ms. Tina Xiao
Ms. Tina Xiao
IR Contact Officer
IR Contact Officer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Gang Lai
Mr. Gang Lai
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
71.89K
--
Ms. Lin Yang
Ms. Lin Yang
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Mr. Baochang Liu
Mr. Baochang Liu
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Jiawen Pang
Mr. Jiawen Pang
Independent Director
Independent Director
--
--
Mr. H. David Sherman
Mr. H. David Sherman
Independent Director
Independent Director
--
--
Mr. Ding Zheng
Mr. Ding Zheng
Independent Director
Independent Director
--
--
FAQs
Who are the top five shareholders of Universe Pharmaceuticals Inc?
The top five shareholders of Universe Pharmaceuticals Inc are: Mr. Gang Lai
How many institutions hold shares of Universe Pharmaceuticals Inc (UPC)?
As of 2026Q1, 15 institutions hold shares of Universe Pharmaceuticals Inc, with a combined market value of approximately 28.11K, accounting for 5.02% of the total shares. Compared to 2025Q4, institutional shareholding has increased by 18652.00.
What is the biggest source of revenue for Universe Pharmaceuticals Inc?
In 2026Q1, the Sales of TCMD products business generated the highest revenue for Universe Pharmaceuticals Inc, amounting to 13.26M and accounting for 74.25% of total revenue.